Relation of D-dimer levels of COVID-19 patients with diabetes mellitusObservational Study Published on 2020-11-012022-10-05 Journal: Diabetes & metabolic syndrome [Category] SARS, 바이오마커, 임상, [키워드] clinical implication Comorbidity COVID COVID-19 COVID-19 infection COVID-19 patient D-dimer D-dimer level D-dimer levels demonstrated diabete diabetes Diabetes Mellitus group hospital hypercoagulable Infection moderate Patient patients with COVID-19 patients with diabete peak peak D-dimer relation severely ill patient significantly higher Statistical tests statistically significant study group was measured with COVID-19 worse prognosis [DOI] 10.1016/j.dsx.2020.09.035 PMC 바로가기 [Article Type] Observational Study
Massive Pulmonary Embolism Complicating Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case ReportCase Report Published on 2020-10-272022-10-31 Journal: Case Reports in Critical Care [Category] COVID-19, [키워드] acute pulmonary embolism Administered afebrile Computed tomography cough Course COVID-19 COVID-19 patient CTPA Diagnosis discharged ECG elevated Embolism etiology Evidence feasible febrile had no healthy heart failure help hemodynamic hemodynamic instability hemodynamic status highlight home quarantine hypercoagulable hypoxic respiratory failure imperative Initially intubation management massive mechanical ventilatory support myalgia Nasopharyngeal swab Oxygenation Pneumonia positive Prognosis pulmonary pulmonary angiography report Respiratory failure risk RT-PCR SARS-COV-2 infection Severe COVID-19 pneumonia Shortness of breath significantly sore throat Swab Tachycardia the patient therapy TTE vasopressor support was obtained worsening [DOI] 10.1155/2020/8875330 PMC 바로가기 [Article Type] Case Report
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid SyndromeCOVID-19의 항인지질 항체는 항인지질 증후군에서 검출되는 항체와 다릅니다Immunology Published on 2020-10-152022-09-11 Journal: Frontiers in Immunology [Category] MERS, SARS, 진단, 치료기술, [키워드] β2-glycoprotein I activated Anti-phospholipid antibodies antibodies antibody Anticoagulant anticoagulation aPTT association Autoimmunity C reactive protein chemiluminescence Coagulopathy coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients Critically ill Critically ill patient critically ill patients death detectable develop domain ELISA epitope epitope specificity evaluate GPI hypercoagulable Hypercoagulable state investigated large cohort leads Lupus lupus anticoagulant objective Organ failure Patient patients Prevalence prothrombin reported Result sera severe COVID-19 specificity syndrome tested thrombosis thrombotic Thrombotic events were used [DOI] 10.3389/fimmu.2020.584241 PMC 바로가기 [Article Type] Immunology
COVID-19 and ischemic stroke: a systematic review and meta-summary of the literatureMeta-Analysis Published on 2020-10-012023-07-11 Journal: Journal of Thrombosis and Thrombolysis [Category] SARS, [키워드] antiphospholipid antibodies COVID-19 hypercoagulable Ischemic Stroke thrombosis [DOI] 10.1007/s11239-020-02228-y PMC 바로가기 [Article Type] Meta-Analysis
COVID-19 Infection Complicated by a Complete Occlusion of the Left Circumflex Artery With Acute Restenosis After Drug-Eluting Stent PlacementCardiology Published on 2020-09-292022-10-31 Journal: Cureus [Category] COVID-19, [키워드] ACS Activated clotting time Acute myocardial infarction acute respiratory syndrome anticoagulation Artery Cardiac arrest circumflex complicate coronary syndrome coronavirus coronavirus disease Course COVID-19 COVID-19 patients descending hypercoagulable involved left management Occlusion Patient Percutaneous coronary intervention physician placement presenting Restenosis SARS-CoV-2 STEMI Stent thrombosis treated Venous Thromboembolism [DOI] 10.7759/cureus.10708 PMC 바로가기 [Article Type] Cardiology
Unfractionated Heparin in SARS-CoV-2 Pneumonia: Ischemic Stroke Case ReportNeurology Published on 2020-09-252022-11-01 Journal: Frontiers in Neurology [Category] COVID-19, [키워드] anticoagulation coagulation parameter Coagulopathy Coronavirus disease 2019 COVID-19 Disseminated intravascular coagulation Effect heparin Hospitalized hypercoagulability hypercoagulable Ischemic Laboratory marker parameter Patient patient with COVID-19 Pneumonia proportion recent report SARS-CoV-2 severe COVID-19 stroke the patient Thromboembolic event Thromboembolism unfractionated heparin [DOI] 10.3389/fneur.2020.573356 PMC 바로가기 [Article Type] Neurology
Glutathione Supplementation as an Adjunctive Therapy in COVID-19Review Published on 2020-09-252022-10-28 Journal: The Cochrane database of systematic reviews [Category] COVID-19, [키워드] caused coronavirus disease COVID-19 COVID-19 patients Cytokine storm Cytokines decrease dysregulated Effect Epidemiology Evidence glutathione GSH HIV Human immunodeficiency virus hypercoagulable IFN-α IFN-β IL-6 immune response inhibit interferon Mortality multi-organ failure Necrosis oxidative stress Pathogenesis patients pulmonary disease the disease TNF-α TNF-α Transmission Treatment Tuberculosis viral replication [DOI] 10.3390/antiox9100914 PMC 바로가기 [Article Type] Review
Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational studyResearch Published on 2020-09-182022-11-01 Journal: Critical Care [Category] COVID-19, SARS, [키워드] Abstract addition age anticoagulation arterial bleeding Characteristics clinical Clinical outcome clinically Clinicians Coagulation Complication complications conducted COVID-19 COVID-19 patient Critically ill patient D-dimer demonstrated embolic evaluated ferritin Haemorrhage heparin hospital hypercoagulable ICU ICU admission ICUs incidence intensive care unit interquartile laboratory data major bleeding male management median multicentre nine Patient patients patients with COVID-19 profile Prophylactic Pulmonary emboli Randomised trial reported Result retrospective tested therapeutic thromboelastography thromboembolic disease thrombosis thrombotic thrombotic complication Thrombotic complications to define venous white cell with COVID-19 [DOI] 10.1186/s13054-020-03260-3 PMC 바로가기 [Article Type] Research
Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone SystemReview Published on 2020-09-042022-10-29 Journal: International Journal of Molecular Sciences [Category] COVID-19, [키워드] ACE2 ACE2/Ang-(1–7)/MasR Activation acute respiratory syndrome age agonist alterations angiotensin-converting enzyme inhibitor anomalies Antiviral apoptotic ARB association blocker cardiovascular cardiovascular damage Cell clinical trial components Coronavirus disease 2019 Coronavirus-2 COVID-19 COVID-19 patients damage decrease disease endothelial cells Genetic help homeostasis hypercoagulable hyperinflammation Hyperinflammatory hypertension hypertensive immunomodulator IMPROVE individual infect Infection liver lung Mortality multiple tissue outcome Pathologies pathology pathway peptides plasma polymorphism RAAS receptor reduce regulate responses SARS-CoV-2 SARS-COV-2 infection severity sex hormone soluble ACE2 Stage susceptibility System targeting Therapies therapy thrombotic Treatment Vaccine vessel viral particle viral propagation [DOI] 10.3390/ijms21186471 PMC 바로가기 [Article Type] Review
Acute Splenic Artery Thrombosis and Infarction Associated with COVID-19 DiseaseCase Report Published on 2020-09-042022-10-31 Journal: Case Reports in Critical Care [Category] COVID-19, [키워드] acute respiratory syndrome Anticoagulant anticoagulation Artery caused coronavirus COVID-19 discharged home disease global pandemic hypercoagulable hypoxemic intermediate dose LMWH Mild Multiple Patient Prophylaxis recommendation reported Respiratory failure SARS-CoV-2 Severe case severe pneumonia Splenic Splenic infarction symptomatic symptoms of COVID-19 thrombosis treated upper respiratory symptom widespread with COVID-19 Wuhan, China [DOI] 10.1155/2020/8880143 PMC 바로가기 [Article Type] Case Report